Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Okuma HS"'
Autor:
Hirakawa A; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan., Asakawa T; Biometrics Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Tokushige K; Advanced Quantitative Sciences, Development Japan, Novartis Pharma K.K., Tokyo, Japan., Ozaki R; Biometrics Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Yoshida M; Department of Biometrics & Data Management, Development Japan, Pfizer R&D Japan G.K., Tokyo, Japan., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan., Shimizu Y; Biostatistics Section, Department of Data Sciences, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Kitabayashi R; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan., Hanazawa R; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan., Sato H; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan., Uemura Y; Biostatistics Section, Department of Data Sciences, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.
Autor:
Kitadai R; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tshimoi@ncc.go.jp., Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hoshino M; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Ito M; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Saito A; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Kita S; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Yoshida M; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Publikováno v:
Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Nov; Vol. 31 (6), pp. 1037-1045. Date of Electronic Publication: 2024 Aug 14.
Autor:
Chiba Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: ychiba@ncc.go.jp., Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: yuukojim@ncc.go.jp., Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: syazaki@ncc.go.jp., Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: hiroyosh@ncc.go.jp., Takamizawa S; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: htakami@ncc.go.jp., Kitadai R; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: rkitadai@ncc.go.jp., Saito A; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: aysaito@ncc.go.jp., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: hsumiyos@ncc.go.jp., Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: tnishika@ncc.go.jp., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: tshimoi@ncc.go.jp., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: ksudo@ncc.go.jp., Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: enoguchi@ncc.go.jp., Uno M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: mauno@ncc.go.jp., Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: miishika@ncc.go.jp., Kato T; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: tokato@ncc.go.jp., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: yfujiwar@ncc.go.jp., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: kyonemor@ncc.go.jp.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 51-57. Date of Electronic Publication: 2024 May 08.
Autor:
Imai T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; yuukojim@ncc.go.jp., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Aiba H; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Saito A; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kita S; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yamamoto K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Maejima A; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Urology and Retroperitoneal Surgery, National Cancer Center Hospital, Tokyo, Japan., Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Matsui Y; Department of Urology and Retroperitoneal Surgery, National Cancer Center Hospital, Tokyo, Japan., Iwata S; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan., Kobayashi E; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan., Kawai A; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan., Udagawa R; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
Anticancer research [Anticancer Res] 2024 May; Vol. 44 (5), pp. 2125-2132.
Autor:
Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan.; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Watanabe K; Division of Cancer Immunology, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, Japan., Tsuchihashi K; Department of Hematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Maidashi Higashi-ku, Fukuoka, Japan., Machida R; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Sadachi R; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Hirakawa A; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo, Japan., Ariyama H; Department of Hematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Maidashi Higashi-ku, Fukuoka, Japan., Kanai M; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Shogoin-kawahara-cho, Sakyo-ku, Kyoto, Japan., Kamikura M; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Anjo K; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Hiramitsu A; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Sekine S; Department of Diagnostic Pathology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Okita N; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Mano H; Division of Cellular Signaling, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo, Japan., Nishikawa H; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tsukiji, Chuo-ku, Tokyo, Japan., Nakamura K; Clinical Research Support Office, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 15; Vol. 29 (24), pp. 5079-5086.
Autor:
Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.; Department of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Okuya T; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Tanioka M; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Tamura K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Tanase Y; Department of Gynecology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Uno M; Department of Gynecology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Arakaki M; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.; Department of Clinical Genomics, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Ichikawa H; Department of Clinical Genomics, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Yagishita S; Department of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Hamada A; Department of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Kato T; Department of Gynecology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Publikováno v:
Gynecologic oncology reports [Gynecol Oncol Rep] 2023 Nov 14; Vol. 50, pp. 101302. Date of Electronic Publication: 2023 Nov 14 (Print Publication: 2023).
Autor:
Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University Graduate School of Medicine, Wakayama, Japan., Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Sudo K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Ichikawa H; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan., Kohsaka S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Sadachi R; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Hirakawa A; Department of Clinical Biostatistics, Tokyo Medical and Dental University, Tokyo, Japan., Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Ando RM; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Ueno T; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Yanagaki M; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Matsui N; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Nakamura K; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Aug 04; Vol. 13 (8), pp. 1814-1825.
Autor:
Watanabe S; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.; Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center East, 5-1, Kashiwanoha 6, Kashiwa, Chiba, 277-8577, Japan., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan. tshimoi@ncc.go.jp., Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Kawachi A; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Tokura M; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Mizoguchi C; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Arakaki M; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Saito A; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Kita S; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Yamamoto K; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Yoshida A; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Publikováno v:
Scientific reports [Sci Rep] 2023 Jul 03; Vol. 13 (1), pp. 10734. Date of Electronic Publication: 2023 Jul 03.
Autor:
Terada M; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan., Nakamura K; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan., Matsuda T; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan., Okuma HS; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Sudo K; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yusof A; Clinical Research Malaysia, Kuala Lumpur, Malaysia., Imasa M; St. Luke's Medical Center, Manila, Philippines., Sirachainan E; Ramathibodi Comprehensive Cancer Center, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.; Thai Society of Clinical Oncology, Bangkok, Thailand., Anh PT; National Cancer Hospital of Vietnam, Hanoi, Vietnam., Fujiwara Y; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Voon PJ; Department of Radiotherapy, Oncology and Palliative Medicine, Hospital Umum Sarawak, Sarawak, Malaysia., Chokephaibulkit K; Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Shibata T; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan., Inoue M; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan., Mano H; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan., Shimoi T; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Sriuranpong V; Thai Society of Clinical Oncology, Bangkok, Thailand.; Department of Medicine, Faculty of Medicine, The King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand., Yonemori K; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Shimada K; National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2023 Jun 29; Vol. 53 (7), pp. 619-628.
Autor:
Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Yoshino T; Department of Pharmacology and Therapeutics, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Tanioka M; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Kazama A; Molecular Genetic Research Department, LSI Medience Corporation, Shimura 3-30-1, Itabashi-ku, Tokyo 174-8555, Japan., Terasaki H; Molecular Genetic Research Department, LSI Medience Corporation, Shimura 3-30-1, Itabashi-ku, Tokyo 174-8555, Japan., Asano S; Life Technologies Japan Ltd., Thermo Fisher Scientific, Shibaura 4-2-8, Minato-ku, Tokyo 108-0023, Japan., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Hamada A; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.; Department of Pharmacology and Therapeutics, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Tamura K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jun 12; Vol. 13 (12). Date of Electronic Publication: 2023 Jun 12.